QA: LIXTE BIOTECHNOLOGY HOLDINGS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335105_2023_LIXTE_BIOTECHNOLOGY_HOLDINGS_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001335105, LIXTE BIOTECHNOLOGY HOLDINGS INC.

  xvar xval
0 AssetsCurrent 5,560,013
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 394,786
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,547,615
9 ResearchAndDevelopmentExpense 1,349,269
10 remainder_Expenses 2,423,472
11 remainder_Revenues 0
12 remainder_NetIncome 7,821
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,560,013
1 Liabilities 394,786
2 Expenses 6,320,356
3 Revenues 0
4 StockholdersEquity 5,165,227
5 NetIncome -6,312,535
6 ComprehensiveNetIncome -6,312,535
7 BaseVar 6,141,488
8 EconomicCapitalRatio 0.864

Edgar->Model Mapping

Feature Distribution

Change over Time